This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Ascentawits Pharmaceuticals, Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Weisu Chen and a Safer Preparation Process for an Imidazole Compound.
Introduction
Weisu Chen is an inventor based in Shenzhen, China, associated with Ascentawits Pharmaceuticals, Ltd. His patent work includes a process for preparing 1-N-methyl-2-nitro-5-hydroxymethylimidazole, a compound produced through a chemical reduction process.
Latest Patents
Chen is associated with 1 patent, titled “Preparation Process of 1-N-Methyl-2-Nitro-5-Hydroxymethyl Imidazole.” The invention describes reacting N,N′-carbonyldiimidazole with 1-N-methyl-2-aminoimidazole-5-carboxylic acid at 45–65°C, then cooling the mixture to 15–25°C until the reaction is complete. A reducing agent is subsequently used to obtain the target compound.
The process replaces isobutyl chloroformate, which the patent describes as highly toxic, strongly irritating, corrosive, and demanding in terms of environmental controls. The proposed reagent, N,N′-carbonyldiimidazole, is a solid that is easier to store and transport and is described as less irritating and corrosive. The patent also highlights simpler reaction handling and post-treatment, reduced equipment demands, and less potential physical harm to operators. Its higher reaction temperature is intended to shorten reaction time and reduce energy consumption, while the process aims to limit side reactions and facilitate purification.
Career Highlights
Chen’s listed patent reflects work on improving the safety and practicality of a chemical preparation process. The invention emphasizes operational simplicity, product purification, and the replacement of a more hazardous reagent with an alternative described as safer to handle.
Collaborations
Chen’s listed coworkers include Zhaoqiang Lu and Jinwei Fan. The available information identifies them as coworkers but does not specify their individual roles in the patent.
Conclusion
Weisu Chen’s patent presents a preparation method designed to make production of 1-N-methyl-2-nitro-5-hydroxymethylimidazole more manageable by using an alternative reagent and simplifying reaction and purification steps.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile